GLP-1 Drugs Are Lowering America’s Obesity Rate
Mihai Andrei, ZME Science America’s obesity rates have constantly been rising. Over 40% of…
FDA approves pill which can prevent heart attack, stroke by reducing inflammation: How it works
The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, for managing cardiovascular risks in adults. This medication, previously for type 2 diabetes, now offers a needle-free option to reduce inflammation and oxidative stress, protecting heart and blood vessels. It also aids blood sugar and weight management, marking a significant advancement in preventative heart […]
Challenging Pfizer, Novo Nordisk Offers Up-to-$9B for Metsera
Intent on growing its leading position in obesity and weight management drugs, Novo Nordisk has made an unsolicited, approximately up-to-$9 billion bid for Metsera—more than a month after Pfizer announced its intent to buy the company for up to $7.3 billion. Novo Nordisk touched off a likely bidding war when it presented what Metsera’s board […]
Microbial metabolism of mannitol as a tracer for the non-invasive measurement of oral-cecal transit
The timing of digestion after a meal reveals information essential for evaluating gastrointestinal function and overall digestive health. Alterations in transit time through the GI tract can reveal abnormalities such as delayed gastric emptying and provide critical insights into nutrient absorption dynamics. This information is particularly valuable for optimizing dietary interventions, managing metabolic conditions such […]
We’re raising our Eli Lilly price target — what a difference a quarter makes
The drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications
Weight Loss Drugs Like Ozempic Are Lowering the U.S. Obesity Rate
The U.S. obesity rate is declining as more people turn to GLP-1 drugs for weight loss. Bloomberg/Getty Images A new Gallup poll indicates that the rate of obesity among U.S. adults has declined over the past three years. The decline is likely attributed to the growing number of people utilizing GLP-1 drugs for weight loss. […]
Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales
Eli Lilly and Company LLY reported third-quarter 2025 adjusted earnings per share (“EPS”) of $7.02, which beat the Zacks Consensus Estimate of $6.02 per share. In the year-ago quarter, Lilly recorded earnings of $1.18 per share. Adjusted EPS included acquired IPR&D charges of 71 cents in the third quarter. Revenues of $17.60 billion rose 54% year […]
Weight-loss drugs may be slimming America faster than anyone expected
The obesity rate in the U.S. is continuing its downward trend. The news comes three years after obesity rates hit a record high. In 2022, almost four out of 10 (39.9%) of Americans met the threshold for the classification, however, the number first began to shrink in 2023. Now, the rate of obesity is now […]
US obesity rates drop in tandem with rising GLP-1 use | Morning in America
The rate of adult obesity in the United States continued its gradual decline in 2025, as the use of GLP-1 weight loss drugs saw a sharp incline, according to new polling from Gallup. NewsNation’s Anna Kooiman breaks down the numbers for “Morning in America.” #Health #Obesity #WeightLoss Start your day with “Morning in America,” NewsNation’s […]
American Obesity Rates Are Now Falling, and It’s Almost Certainly Because of Ozempic
For decades, the obesity rate among Americans trended inexorably higher, to a peak of 39.9 percent in 2022. But now, new data from Gallup’s National Health and Well-Being Index shows that something extraordinary has happened: that longstanding trend has reversed, with the obesity rate falling back down to 37 percent this year. “This is a […]